Articles published in Journal of Oncology Translational Research have been cited by esteemed scholars and scientists all around the world.
Journal of Oncology Translational Research has got h-index 4, which means every article in Journal of Oncology Translational Research has got 4 average citations.
Following are the list of articles that have cited the articles published in Journal of Oncology Translational Research.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total published articles |
30 | 32 | 46 | 9 | 9 |
Conference proceedings |
0 | 0 | 0 | 0 | 37 |
Citations received as per Google Scholar, other indexing platforms and portals |
13 | 12 | 15 | 7 | 5 |
Journal total citations count | 93 |
Journal impact factor | 0.17 |
Journal 5 years impact factor | 0.46 |
Journal h-index | 4 |
Journal h-index since 2019 | 3 |
Majumder D, Das M (2016) An analytical approach for leukemia diagnosis from light microscopic images of Rbcs (Computational approach for leukemia diagnosis). 2nd International Conference on Next Generation Computing Technologies. |
|
Alimohamadi H, Smith AS, Fowler VM, Rangamani P (2019) Non-uniform distribution of myosin-mediated forces governs red blood cell curvature through tension modulation. bioRxiv 1: 668582 |
|
Majumder D, Das M (2019) Digital Image Analysis for Early Diagnosis of Cancer: Identification of Pre-Cancerous State. Histopathological Image Analysis in Medical Decision Making. |
|
Indranil C (2016) Common Denominator in Liver Disease: A communication report; Focus on Reversing the Scarring that’s Common to Liver Diseases. Journal of Medical and Health Sciences. |
|
Chen D (2017) The newest medicine: Chimeric antigen receptor T-Cell immunotherapy (CAR-T). J Transl Res 1: 1-2. |
|
Indranil C. Journal of Medical and Health Sciences. |
|
Chen D (2018) Dual targeting autoimmunity and cancer: From biology to medicine. The Journal of Clinical Pharmacology 58: 990-996. |
|
Russi S, Verma HK, Laurino S, Mazzone P, Storto G, et al. (2019) Adapting and surviving: intra and extra-cellular remodeling in drug-resistant gastric cancer cells. International journal of molecular sciences 20: 3736. |
|
Chen D (2019) Dually Efficacious Medicine Against Fibrosis and Cancer. Medical Sciences 7: 41. |
|
Chen D, Zhang X (2017) Cellular immunity augmentation in mainstream oncologic therapy. Cancer biology & medicine 14: 121-128. |
|
Dhar PK, Naskar TK, Majumder D (2017) An Analytical Approach for the Determination of Chemotherapeutic Drug Application Trade-Offs in Leukemia. International Conference on Next Generation Computing Technologies : 390-404. |
|
Dhar PK, Naskar TK, Majumder D (2017) Predictive model for stem cell transplantation with suicidal gene construct for the treatment of leukemia: Analytical model for gene therapy of leukemia. Int Conf Int Com Comp Tech :194-199. |
|
Dhar PK, Naskar TK, Majumder D. (2018) Prediction of Drug Application Optimization Based on RBC Dynamics in Maintenance Chemotherapy of Acute Lymphoblastic Leukemia Maintenance. Int Confe Bio Sys Bio : 1-5. |
|
Kamini J (2017) Why Imatinib is by Far the Best Drug to Treat Chronic Myeloid Leukemia. Biochem Mol Biol Lett 3: 112. |
|
Anitha SS, Prudhvi RP (2017) Incidence and Prevalence of Breast Cancer in USA. Biochem Mol Biol Lett 2: 102. |
|
Li Z, Gong X, Zhang W, Zhang J, Ding L, et al. (2019) Inhibition of miRNA‑34a promotes triple negative cancer cell proliferation by promoting glucose uptake. Experimental and Therapeutic Medicine 18: 3936-3942. |
|
Lee JO, Kang MJ, Byun WS, Kim SA, Seo IH, et al. (2019) Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51. Breast Cancer Research 21: 1-8. |
|
Varghese S, Samuel S, Varghese E, Kubatka P, Büsselberg D (2019) High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells. Biomolecules 9: 16. |
|
Zhu S, Wei L, Lin G, Tong Y, Zhang J et al. (2019) Metabolic Alterations Induced by Kudingcha Lead to Cancer Cell Apoptosis and Metastasis Inhibition. Nutrition and cancer 26: 1-2. |
|
Yin X, Wei Z, Song C, Tang C, Xu W, et al. (2018) Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal. Cancer management and research 10: 5785. |
|
Journal of Oncology Translational Research received 93 citations as per Google Scholar report